MedPath

Mulligan Mobilization Versus Instrument Assissted Soft Tissue Mobilization In Chronic Iateral Epicondylitis

Not Applicable
Not yet recruiting
Conditions
Lateral Epicondylitis
Interventions
Other: mulligan mobilization
Other: instrumented assisted soft tissue mobilization
Other: conventional treatment
Registration Number
NCT05780528
Lead Sponsor
Cairo University
Brief Summary

this study will be conducted to compare between mulligan mobilization and instrument assisted soft tissue mobilization on pain intensity, range of motion, hand grip strength, and hand function in the treatment of chronic lateral epicondylitis

Detailed Description

Lateral epicondylitis is one of the elbow conditions that affects about 1-3% of the population at large. It produces a heavy burden of workdays lost and residual impairments. Although many treatment modalities are used, few of them rest on scientific evidence and none has been proven more effective than the others. This lack of evidence on treatments for lateral epicondylitis may stem from several sources, including the possible self-limiting nature of the condition, the lack of pathophysiological data, the methodological shortcomings of available studies, and the existence of numerous factors influencing the outcome. The physiotherapeutic treatment has been shown to be effective. In general, it must include manual therapy to relieve the pain and improve the joint's range of motion (ROM), taking into account that it must be performed under the pain threshold. Mulligan mobilization with movement (MWM) is a modern technique developed by Mulligan for treating lateral epicondylitis (LE). Instrument-assisted soft tissue mobilization is a form of augmented soft tissue mobilization (IASTM) in which stainless steel instruments are utilized to apply controlled microtrauma to the affected soft tissues. sixty patients will be allocated randomly to three groups; the first one will receive mulligan mobilization with movement, the second one will receive instrument-assisted soft tissue mobilization and the third one will receive traditional therapy three times a week for four weeks

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
60
Inclusion Criteria

All patients will be diagnosed with chronic lateral epicondylitis from both genders.

Patients with chronic lateral epicondylitis were diagnosed by orthopedists. Positive clinical manifestation in all patients. Patients' age will be ranged from 18 to 80 years, Pain onset is more than 3 months. All participants must be medically stable and not be treated with analgesics or any medication which may cause misleading results.

All patients have a body mass index between 18.5 and 29.9 kg/m2.

Exclusion Criteria

Patients who received an intra-articular injection for a duration of less than 3 months.

Patients receiving oral or injected corticosteroids for the last 3 months at least.

History of elbow surgery/fracture. Acute synovitis/arthritis including infectious. Presence of malignancy. Pregnancy. Patients with, topical lesions, contact dermatitis, and a history of cutaneous hypersensitivity

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
mulligan mobilizationmulligan mobilizationthe patients will receive mulligan mobilization three times a week for four weeks
mulligan mobilizationconventional treatmentthe patients will receive mulligan mobilization three times a week for four weeks
conventional treatmentconventional treatmentthe patients will receive conventional treatment three times a week for four weeks
instrumented assisted soft tissue mobilizationinstrumented assisted soft tissue mobilizationthe patients will receive instrumented assisted soft tissue mobilization three times a week for four weeks
instrumented assisted soft tissue mobilizationconventional treatmentthe patients will receive instrumented assisted soft tissue mobilization three times a week for four weeks
Primary Outcome Measures
NameTimeMethod
pain intensityup to four weeks

pain will be measured by visual analogue scale. It is a vertical or horizontal 100 mm line graduated by different levels of pain, starting from 0 (no pain) till 100 (worst pain)

shoulder disabilityup to four weeks

The Arabic version of Disabilities of arm, shoulder, and hand (DASH) will be used for assessing shoulder function.DASH questionnaire includes 11 items with score from 0 to 100. A score of 0 represents no disability, while a score of 100 represents the most sever

Secondary Outcome Measures
NameTimeMethod
hand grip strengthup to four weeks

Hand held dynamometer will be used to measure hand grip strength

range of motionup to four weeks

elbow and wrist range of motion will be measured by universal goniometer

© Copyright 2025. All Rights Reserved by MedPath